Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced the establishment of the StrategiesPlus™ COVID-19 ACT Program to speed consulting assistance to any organization involved in coronavirus research.
March 26, 2020
· 4 min read